Cellular Metabolism and Dose Reveal Carnitine-Dependent and -Independent Mechanisms of Butyrate Oxidation in Colorectal Cancer Cells

Journal of Cellular Physiology

Volumn 231, Issue 8, 2016, Pages 1804-1813

  Han, Anna ^a   Bennett, Natalie ^a   Macdonald, Amber ^a   Johnstone, Megan ^a   Whelan, Jay ^a   Donohoe, Dallas R ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; BUTYRIC ACID; CARNITINE; DICHLOROACETIC ACID; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; PROPIONIC ACID; PYRUVATE DEHYDROGENASE; ANTINEOPLASTIC AGENT; CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE 1A, HUMAN; HISTONE; ORGANIC CATION TRANSPORTER; PYRUVATE DEHYDROGENASE COMPLEX; SLC22A5 PROTEIN, HUMAN;

AEROBIC METABOLISM; ARTICLE; CELL METABOLISM; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; HISTONE ACETYLATION; HUMAN; HUMAN CELL; OXIDATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ACETYLATION; ANTAGONISTS AND INHIBITORS; COLORECTAL NEOPLASMS; DOSE RESPONSE; DRUG EFFECTS; ENERGY METABOLISM; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; HCT116 CELL LINE; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTOR;

ACETYLATION; ANTINEOPLASTIC AGENTS; BUTYRIC ACID; CARNITINE; CARNITINE O-PALMITOYLTRANSFERASE; COLORECTAL NEOPLASMS; DICHLOROACETIC ACID; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; HCT116 CELLS; HISTONE DEACETYLASE INHIBITORS; HISTONES; HUMANS; ORGANIC CATION TRANSPORT PROTEINS; OXIDATION-REDUCTION; PHOSPHORYLATION; PYRUVATE DEHYDROGENASE COMPLEX; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 84953439572     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25287     Document Type: Article

References (51)

1. Andriamihaja M, Chaumontet C, Tome D, Blachier F. 2009. Butyrate metabolism in human colon carcinoma cells: Implications concerning its growth-inhibitory effect. J Cell Physiol 218:58-65.
2. Archer SY, Meng S, Shei A, Hodin RA. 1998. P21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA 95:6791-6796.
3. Bae S, Ulrich CM, Neuhouser ML, Malysheva O, Bailey LB, Xiao L, Brown EC, Cushing-Haugen KL, Zheng Y, Cheng TY, Miller JW, Green R, Lane DS, Beresford SA, Caudill MA. 2014. Plasma choline metabolites and colorectal cancer risk in the Women's Health Initiative Observational Study. Cancer Res 74:7442-7452.
4. Balamurugan R, Rajendiran E, George S, Samuel GV, Ramakrishna BS. 2008. Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J Gastroenterol Hepatol 23:1298-1303.
5. Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, Norat T, Clavel-Chapelon F, Kesse E, Nieters A, Boeing H, Tjonneland A, Overvad K, Martinez C, Dorronsoro M, Gonzalez CA, Key TJ, Trichopoulou A, Naska A, Vineis P, Tumino R, Krogh V, Bueno-de-Mesquita HB, Peeters PH, Berglund G, Hallmans G, Lund E, Skeie G, Kaaks R, Riboli E. 2003. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): An observational study. Lancet 361:1496-1501.
6. Bruce WR, Wolever TM, Giacca A. 2000. Mechanisms linking diet and colorectal cancer: The possible role of insulin resistance. Nutr Cancer 37:19-26.
7. Ceccarelli SM, Chomienne O, Gubler M, Arduini A. 2011. Carnitine palmitoyltransferase (CPT) modulators: A medicinal chemistry perspective on 35 years of research. J Med Chem 54:3109-3152.
8. Chopin V, Toillon RA, Jouy N, Le Bourhis X. 2002. Sodium butyrate induces P53-independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells. Br J Pharmacol 135:79-86.
9. de Geus-Oei LF, Ruers TJ, Punt CJ, Leer JW, Corstens FH, Oyen WJ. 2006. FDG-PET in colorectal cancer. Cancer Imaging 6:S71-S81.
10. De Preter V, Geboes KP, Bulteel V, Vandermeulen G, Suenaert P, Rutgeerts P, Verbeke K. 2011. Kinetics of butyrate metabolism in the normal colon and in ulcerative colitis: The effects of substrate concentration and carnitine on the beta-oxidation pathway. Aliment Pharmacol Ther 34:526-532.
11. Delbeke D, Martin WH. 2011. FDG PET and PET/CT for colorectal cancer. Methods Mol Biol 727:77-103.
12. Donohoe DR, Collins LB, Wali A, Bigler R, Sun W, Bultman SJ. 2012a. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell 48:612-626.
13. Donohoe DR, Collins LB, Wali A, Bigler R, Sun W, Bultman SJ. 2012b. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell 48:612-626.
14. Donohoe DR, Garge N, Zhang X, Sun W, O'Connell TM, Bunger MK, Bultman SJ. 2011. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 13:517-526.
15. Donohoe DR, Holley D, Collins LB, Montgomery SA, Whitmore AC, Hillhouse A, Curry KP, Renner SW, Greenwalt A, Ryan EP, Godfrey V, Heise MT, Threadgill DS, Han A, Swenberg JA, Threadgill DW, Bultman SJ. 2014. A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. Cancer Discov 4:1387-1397.
16. Fan J, Kang HB, Shan C, Elf S, Lin R, Xie J, Gu TL, Aguiar M, Lonning S, Chung TW, Arellano M, Khoury HJ, Shin DM, Khuri FR, Boggon TJ, Kang S, Chen J. 2014. Tyr-301 phosphorylation inhibits pyruvate dehydrogenase by blocking substrate binding and promotes the Warburg effect. J Biol Chem 289:26533-26541.
17. Flint HJ, Scott KP, Duncan SH, Louis P, Forano E. 2012. Microbial degradation of complex carbohydrates in the gut. Gut Microbes 3:289-306.
18. Fritz IB. 1959. Action of carnitine on long chain fatty acid oxidation by liver. Am J Physiol 197:297-304.
19. Fritz IB. 1961. Factors influencing the rates of long-chain fatty acid oxidation and synthesis in mammalian systems. Physiol Rev 41:52-129.
20. Fritz IB, Kaplan E, Yue KT. 1962. Specificity of carnitine action on fatty acid oxidation by heart muscle. Am J Physiol 202:117-121.
21. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Stampfer MJ, Rosner B, Speizer FE, Willett WC. 1999. Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med 340:169-176.
22. Giovannucci E, Stampfer MJ, Colditz G, Rimm EB, Willett WC. 1992. Relationship of diet to risk of colorectal adenoma in men. J Natl Cancer Inst 84:91-98.
23. Hird FJ, Weidemann MJ. 1966. Oxidative phosphorylation accompanying oxidation of short-chain fatty acids by rat-liver mitochondria. Biochem J 98:378-388.
24. Hitosugi T, Fan J, Chung TW, Lythgoe K, Wang X, Xie J, Ge Q, Gu TL, Polakiewicz RD, Roesel JL, Chen GZ, Boggon TJ, Lonial S, Fu H, Khuri FR, Kang S, Chen J. 2011. Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism. Mol Cell 44:864-877.
25. Izquierdo-Garcia JL, Viswanath P, Eriksson P, Cai L, Radoul M, Chaumeil MM, Blough M, Luchman HA, Weiss S, Cairncross JG, Phillips JJ, Pieper RO, Ronen SM. 2015. IDH1 mutation induces reprogramming of pyruvate metabolism. Cancer Res 75:2999-3009.
26. Kawada K, Toda K, Nakamoto Y, Iwamoto M, Hatano E, Chen F, Hasegawa S, Togashi K, Date H, Uemoto S, Sakai Y. 2015. Relationship between FDG-PET/CT scans and KRAS mutations in metastatic colorectal cancer. J Nucl Med.
27. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, DiDonato JA, Chen J, Li H, Wu GD, Lewis JD, Warrier M, Brown JM, Krauss RM, Tang WH, Bushman FD, Lusis AJ, Hazen SL. 2013. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19:576-585.
28. Lanza E, Yu B, Murphy G, Albert PS, Caan B, Marshall JR, Lance P, Paskett ED, Weissfeld J, Slattery M, Burt R, Iber F, Shike M, Kikendall JW, Brewer BK, Schatzkin A. 2007. The polyp prevention trial continued follow-up study: No effect of a low-fat, high-fiber, high-fruit, and -vegetable diet on adenoma recurrence eight years after randomization. Cancer Epidemiol Biomarkers Prev 16:1745-1752.
29. Leschelle X, Delpal S, Goubern M, Blottiere HM, Blachier F. 2000. Butyrate metabolism upstream and downstream acetyl-CoA synthesis and growth control of human colon carcinoma cells. Eur J Biochem 267:6435-6442.
30. Louis P, Hold GL, Flint HJ. 2014. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 12:661-672.
31. Mai V, Flood A, Peters U, Lacey JV, Jr., Schairer C, Schatzkin A. 2003. Dietary fibre and risk of colorectal cancer in the Breast Cancer Detection Demonstration Project (BCDDP) follow-up cohort. Int J Epidemiol 32:234-239.
32. Ohashi R, Tamai I, Nezu Ji J, Nikaido H, Hashimoto N, Oku A, Sai Y, Shimane M, Tsuji A. 2001. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OC TN2. Mol Pharmacol 59:358-366.
33. Reddy BS. 1999. Role of dietary fiber in colon cancer: An overview. Am J Med 106:16S-19S. discussion 50S-51S.
34. Roediger WE. 1980. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21:793-798.
35. Roediger WE, Nance S. 1990. Selective reduction of fatty acid oxidation in colonocytes: Correlation with ulcerative colitis. Lipids 25:646-652.
36. Ryan-Harshman M, Aldoori W. 2007. Diet and colorectal cancer: Review of the evidence. Can Fam Phys 53:1913-1920.
37. Safari A, Shariff ZM, Kandiah M, Rashidkhani B, Fereidooni F. 2013. Dietary patterns and risk of colorectal cancer in Tehran Province: A case-control study. BMC Public Health 13:222.
38. Scalise M, Galluccio M, Accardi R, Cornet I, Tommasino M, Indiveri C. 2012. Human OCTN2 (SLC22A5) is down-regulated in virus- and nonvirus-mediated cancer. Cell Biochem Funct 30:419-425.
39. Schatzkin A, Mouw T, Park Y, Subar AF, Kipnis V, Hollenbeck A, Leitzmann MF, Thompson FE. 2007. Dietary fiber and whole-grain consumption in relation to colorectal cancer in the NIH-AARP diet and health study. Am J Clin Nutr 85:1353-1360.
40. Seth P, Wu X, Huang W, Leibach FH, Ganapathy V. 1999. Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function. J Biol Chem 274:33388-33392.
41. van Kouwen MC, Laverman P, van Krieken JH, Oyen WJ, Nagengast FM, Drenth JP. 2006. Noninvasive monitoring of colonic carcinogenesis: Feasibility of [(18)F]FDG-PET in the azoxymethane model. Nucl Med Biol 33:245-248.
42. Vargas AJ, Thompson PA. 2012. Diet and nutrient factors in colorectal cancer risk. Nutr Clin Pract 27:613-623.
43. Vargas AJ, Wertheim BC, Gerner EW, Thomson CA, Rock CL, Thompson PA. 2012. Dietary polyamine intake and risk of colorectal adenomatous polyps. Am J Clin Nutr 96:133-141.
44. Velcich A, Palumbo L, Jarry A, Laboisse C, Racevskis J, Augenlicht L. 1995. Patterns of expression of lineage-specific markers during the in vitro-induced differentiation of HT29 colon carcinoma cells. Cell Growth Differ 6:749-757.
45. Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, Jia W, Cai S, Zhao L. 2012. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 6:320-329.
46. Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. 2009. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324:1076-1080.
47. Whitehouse S, Cooper RH, Randle PJ. 1974. Mechanism of activation of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxylic acids. Biochem J 141:761-774.
48. Willett WC. 2001. Diet and cancer: One view at the start of the millennium. Cancer Epidemiol Biomarkers Prev 10:3-8.
49. Wollowski I, Rechkemmer G, Pool-Zobel BL. 2001. Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr 73:451S-455S.
50. Wu X, Huang W, Prasad PD, Seth P, Rajan DP, Leibach FH, Chen J, Conway SJ, Ganapathy V. 1999. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 290:1482-1492.
51. Xu R, Wang Q, Li L. 2015. A genome-wide systems analysis reveals strong link between colorectal cancer and trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fat. BMC Genomics 16:S4.